Latest Breaking News On - Wesana health holdings inc - Page 8 : comparemela.com

Canadian Securities Exchange (CSE): CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO

Canadian Securities Exchange (CSE): CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesRichard carletonKostenloser wertpapierhandelAmuka esportsMary agrotechnologies incBrands incWesana health holdings incExchange youtubeGlobal helium corpDefence therapeutics incClearmind medicine incFathom nickel incGroup incWellness ltdNewsfile corpAlpha esports tech inc

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesJames fadimanAllison sossNick opich annie grafDaniel carcilloStrategic communicationsNational public televisionWesana healthWesana health holdings incWesana health holdingsScientific advisoryScientific advisory boardChad bronsteinNational publicLooking informationListing statement

Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer

Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesMark wingertzahnAllison sossNick opich annie grafDaniel carcilloGlobal clinical developmentWesana research leadership teamProfessor of life sciences allied healthStrategic communicationsWesana healthScientific affairsWesana health holdings incClinical developmentHealth holdingsChief scientificPreclinical medicine

Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public

Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public Compass Pathways (NASDAQ:CMPS) and MindMed (NASDAQ:MNMD) remain the only two companies in psychedelics to reach a major U.S. stock exchange. Both companies presented net losses associated with R&D expenses, as entities in the space race towards gaining ground in a sector that still hasn’t reached early maturity or profitability. Both companies presented strong cash positions to advance their research pipelines. Compass, Pressing On Psilocybin: Compass highlighted the issuing of two new patents and a post-quarter equity financing round of $144 million.

University of the west indiesSaint andrewCosta ricaRick doblinDouglask gordonKaivalya kollectivDaniel carcilloBraxia scientific corpWesana health goes publicIntelgenx technologies corpExcellence incMultidisciplinary association of psychedelicWesana health holdings incCanadian securities exchangeCanadian rapid treatment centerBraxia health

BioSpace Global Roundup: Shanghai Ecosystem Grows with Addition of Germany s ITM AG

Published: May 12, 2021 By Alex Keown Shanghai continues to be an area of focus for many pharmaceutical companies seeking a toehold in China. Companies like AstraZeneca, Novartis and others have opened offices in Shanghai. Two months ago, Germany’s Vetter, a contract development and manufacturing organization, opened offices there, and now, ITM AG, another Germany-based company is following suit. ITM AG established a subsidiary in Shanghai to accelerate introduction of its precision oncology portfolio in China. The subsidiary will expand ITM’s growing operations in China, which is a key emerging market for novel radiomolecular precision oncology. The ITM Shanghai team will focus on expanding and accelerating access of targeted therapeutic and diagnostic radiopharmaceuticals for Chinese patients.

South koreaSchleswig holsteinLytix biopharmaFairjourney biologicsPhico saspjectHofseth biocarePhico therapeutics ltdWesana health incClinical cancer research studyHelm biologics gmbh coWesana healthWesana health holdings incHubrecht instituteHelm biologicsRichter helm biologics gmbhAsia pacific